Enanta

-$1.54 (-3.93%) As of 4:10 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Enanta and other ETFs, options, and stocks.

About ENTA

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases.

CEO
Jay R. Luly
Employees
155
Headquarters
Watertown, Massachusetts
Founded
1995

ENTA Key Statistics

Market cap
780.66M
Price-Earnings ratio
—
Dividend yield
—
Average volume
432.19K
High today
$39.87
Low today
$37.68
Open price
$39.08
Volume
60.98K
52 Week high
$102.00
52 Week low
$37.68

ENTA News

MarketWatchMay 19

Enanta's stock is down after its experimental RSV treatment failed in a mid-stage clinical trial

Shares of Enanta Pharmaceuticals Inc. ENTA, -6.24% slid 19.3% in premarket trading on Thursday, the day after the company said its experimental treatment for re
MarketWatchMay 18

Enanta Pharma Shares Fall After EDP-938 Study Doesn't Meet Primary Endpoint - MarketWatch

By Stephen Nakrosis Shares of biotechnology company Enanta Pharmaceuticals Inc. were lower in Wednesday's late-trading session, after the company said a study
BenzingaMay 18

Enanta Pharmaceuticals Shares Fall After RSVP Phase 2b study results Miss Primary Endpoint

Enanta Pharmaceuticals, Inc. ENTA today announced the topline results for RSVP clinical study evaluating EDP-938, in otherwise healthy adults with community-acq

ENTA Earnings

-$1.63
-$1.09
-$0.54
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure